Live feed
Filing
SC 13G
SC 13G0001193125-19-106750·LIGAND PHARMACEUTICALS INC
Schedule 13G ownership disclosure
APRICUS BIOSCIENCES INC
Security class unavailable · CUSIP: 81577F109
Event date: 2019-02-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-106750
- Form type
- SC 13G
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- Apr 15, 2019
- Reporting period
- Feb 27, 2019
- Description
- Schedule 13G beneficial ownership